RNA-seq analysis of NCI-H1693 cells treated with the selective SMARCA2 degrader PRT3789
RNA-seq (gene expression) · human · 18 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 18 samples: 6 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE307424_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1321601 and SRA study SRP618255. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 18 samples.
How we read this: 6 replicated groups read from 18 sample titles; they account for 18 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9223906 NCI-H1693, DMSO, 6 hr, rep1 NCI-H1693, DMSO, 6 hr,
- GSM9223907 NCI-H1693, DMSO, 6 hr, rep2 NCI-H1693, DMSO, 6 hr,
- GSM9223908 NCI-H1693, DMSO, 6 hr, rep3 NCI-H1693, DMSO, 6 hr,
- GSM9223909 NCI-H1693, PRT3789, 6 hr, rep1 NCI-H1693, PRT3789, 6 h…
- GSM9223910 NCI-H1693, PRT3789, 6 hr, rep2 NCI-H1693, PRT3789, 6 h…
- GSM9223911 NCI-H1693, PRT3789, 6 hr, rep3 NCI-H1693, PRT3789, 6 h…
- GSM9223912 NCI-H1693, DMSO, 48 hr, rep1 NCI-H1693, DMSO, 48 hr,
- GSM9223913 NCI-H1693, DMSO, 48 hr, rep2 NCI-H1693, DMSO, 48 hr,
- GSM9223914 NCI-H1693, DMSO, 48 hr, rep3 NCI-H1693, DMSO, 48 hr,
- GSM9223915 NCI-H1693, PRT3789, 48 hr, rep1 NCI-H1693, PRT3789, 48 …
- GSM9223916 NCI-H1693, PRT3789, 48 hr, rep2 NCI-H1693, PRT3789, 48 …
- GSM9223917 NCI-H1693, PRT3789, 48 hr, rep3 NCI-H1693, PRT3789, 48 …
- GSM9223918 NCI-H1693, DMSO, 72 hr, rep1 NCI-H1693, DMSO, 72 hr,
- GSM9223919 NCI-H1693, DMSO, 72 hr, rep2 NCI-H1693, DMSO, 72 hr,
- GSM9223920 NCI-H1693, DMSO, 72 hr, rep3 NCI-H1693, DMSO, 72 hr,
- GSM9223921 NCI-H1693, PRT3789, 72 hr, rep1 NCI-H1693, PRT3789, 72 …
- GSM9223922 NCI-H1693, PRT3789, 72 hr, rep2 NCI-H1693, PRT3789, 72 …
- GSM9223923 NCI-H1693, PRT3789, 72 hr, rep3 NCI-H1693, PRT3789, 72 …
- GSE245926 A potent and selective small-molecule degrader of ENL suppresses leukemia progression in vivo (RNA-Seq) 42 samples shares selective, degrader, rna-seq
- GSE236588 Enhancer reprogramming underlies therapeutic utility of a SMARCA2 degrader in SMARCA4 mutant cancer [ATAC-Seq] 24 samples shares smarca2, degrader
- GSE280803 ChIP-seq of trascription factors after SMARCA2/4 degrader treatment 21 samples shares smarca2, degrader
- GSE236589 Enhancer reprogramming underlies therapeutic utility of a SMARCA2 degrader in SMARCA4 mutant cancer [ChIP-Seq] 12 samples shares smarca2, degrader
- GSE269909 Divergent medulloblastoma chromatin states disclose KDM2B as a selective dependency [RNA-Seq] 50 samples shares selective, rna-seq
- GSE273492 Selective NSD2 Inhibition Reveals an Epigenetic Vulnerability of KRAS-Driven Cancers [RNA-Seq] 36 samples shares selective, rna-seq
- GSE261563 G-quadruplex stabilizer CX-5461 effectively combines with ionizing radiation to selectively target ATRX-deficient malignant glioma [RNA-seq] 30 samples shares selective, rna-seq
- GSE295708 Selective remodelling of the adipose niche in obesity and weight loss [snRNA-Seq] 18 samples shares selective, rna-seq
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.